Your browser doesn't support javascript.
loading
Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
Stange, M A; Tutarel, O; Pischke, S; Schneider, A; Strassburg, C P; Becker, T; Barg-Hock, H; Bastürk, M; Wursthorn, K; Cornberg, M; Ott, M; Greten, T F; Manns, M P; Wedemeyer, H.
Affiliation
  • Stange MA; Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
Z Gastroenterol ; 48(2): 258-63, 2010 Feb.
Article in En | MEDLINE | ID: mdl-20127601
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Virus Activation / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, B-Cell / Liver Failure / Lymphoma, B-Cell, Marginal Zone / Hepatitis B / Immunologic Factors / Antibodies, Monoclonal Limits: Humans / Male / Middle aged Language: En Journal: Z Gastroenterol Year: 2010 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Virus Activation / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, B-Cell / Liver Failure / Lymphoma, B-Cell, Marginal Zone / Hepatitis B / Immunologic Factors / Antibodies, Monoclonal Limits: Humans / Male / Middle aged Language: En Journal: Z Gastroenterol Year: 2010 Document type: Article Affiliation country: